Preparat som främjar ökad energiförbrukning och viktminskning genom nervsignal- och kemisk reglering. Betaadrenerga och serotoninerga läkemedel har använts experimentellt mot övervikt hos patienter med icke-insulinberoende diabetes mellitus (NIDDM).
Agents that increase energy expenditure and weight loss by neural and metabolic regulation.
Bantningsmedel — Medel mot fetma — Medel mot övervikt — Viktminskningsmedel
Agents, Anti-Obesity — Anti Obesity Agents — Anti-Obesity Drugs — Anti Obesity Drugs — Drugs, Anti-Obesity — Anti-Obesity Agent — Agent, Anti-Obesity — Anti Obesity Agent — Antiobesity Agent — Agent, Antiobesity — Antiobesity Drugs — Drugs, Antiobesity — Anti-Obesity Drug — Anti Obesity Drug — Drug, Anti-Obesity — Antiobesity Agents — Agents, Antiobesity — Antiobesity Drug — Drug, Antiobesity — Weight-Loss Agents — Agents, Weight-Loss — Weight Loss Agents — Weight-Loss Drugs — Drugs, Weight-Loss — Weight Loss Drugs — Weight-Loss Drug — Drug, Weight-Loss — Weight Loss Drug